Stem cell function gradually declines with age because the cells accumulate biological stress over time. DNA damage, mitochondrial dysfunction, oxidative stress, epigenetic changes, cellular senescence, and changes in the surrounding tissue environment can all reduce their ability to divide, communicate, and support tissue repair.
This does not mean that an older person’s stem cells suddenly stop working. Aging is gradual, and there is substantial variation between individuals.
It does, however, help explain why younger tissues often have stronger regenerative capacity and why perinatal sources such as umbilical cord tissue are of interest in regenerative medicine.
What Do Stem Cells Normally Do in the Body?
Stem cells help maintain and repair tissues throughout life. Different tissues contain populations of stem or progenitor cells that can respond when cells are lost or damaged. Mesenchymal stromal cells, or MSCs, are also involved in tissue signaling, immune regulation, and communication with surrounding cells.
Their role is not simply to transform into replacement tissue. MSCs release signaling molecules that can influence inflammation, immune activity, blood vessel formation, and tissue repair. Maintaining these functions requires healthy cellular metabolism and tightly controlled gene activity.
As the body ages, some of these systems become less efficient. A recent review of stem cell aging describes progressive changes in self-renewal, differentiation, cellular identity, and regenerative output as important features of aging stem cell populations.
What Is Cellular Senescence?
Cellular senescence is one of the main processes associated with declining stem cell function. A senescent cell is still alive, but it has largely stopped dividing normally.
This can occur after repeated cell division or in response to stress, DNA damage, oxidative injury, and other biological signals. Senescence can be protective because it prevents damaged cells from continuing to multiply. The problem develops when senescent cells accumulate.
Older MSC populations have been associated with increased expression of markers linked to cellular senescence and DNA damage, including p16, p21, and p53. A systematic review examining donor age found that these changes were accompanied by greater oxidative stress and lower expression of several markers associated with cell proliferation.
Senescent cells can also release inflammatory molecules that alter the surrounding cellular environment. This means aging can affect not only the individual stem cell but also the signals received by nearby cells.
Why Does DNA Damage Increase With Age?
Cells are exposed to DNA damage throughout life. The body has sophisticated repair systems, but these systems are not perfect. Over decades, repeated cellular stress can allow damage to accumulate.
Stem cells must protect their genetic material because they may remain in tissues for many years. When DNA damage becomes significant, cells may slow their division, enter senescence, or change their normal behavior.
A 2026 review of stem cell aging identified genomic stress, telomere changes, altered DNA repair, epigenetic disruption, and cellular senescence as interconnected mechanisms that can reduce stem cell self-renewal and regenerative capacity. The result is not necessarily cell death. More often, the cell gradually becomes less efficient.
What Happens to Mitochondria as Stem Cells Age?
Mitochondria help regulate cellular energy, metabolism, stress responses, and signaling. With age, mitochondrial function can become less efficient. Studies of human MSCs have found age-related changes in mitochondrial membrane function, energy metabolism, and reactive oxygen species production. These metabolic changes can make older cells more vulnerable to stress.
Reactive oxygen species are normal by-products of cellular metabolism. In controlled amounts, they participate in signaling. When oxidative stress becomes excessive, however, it can damage DNA, proteins, and cell membranes. This creates a cycle in which mitochondrial dysfunction contributes to oxidative stress, which can then produce further cellular damage. More recent research continues to identify mitochondrial dysfunction as an important contributor to stem cell exhaustion and age-related inflammatory signaling.
Do Stem Cells Become Less Able to Divide With Age?
In many stem cell populations, yes. Older cells often show reduced proliferative capacity, meaning they may divide more slowly or complete fewer successful cycles of expansion.
For example, research examining bone marrow from healthy human donors aged 19 to 89 found that the number of measurable MSCs within bone marrow generally declined with increasing age. Researchers also observed lower colony-forming capacity in older groups.
However, the same study found substantial differences between individuals and cautioned that chronological age alone was not a reliable measure of MSC potency. This is an important distinction. Age influences cell biology, but a person’s age by itself does not tell us exactly how functional their stem cells are. Health, metabolic status, disease, lifestyle, tissue source, manufacturing, and laboratory expansion can also influence cell characteristics.
Does the Environment Around Stem Cells Age Too?
Yes. Stem cells do not function independently. They live within a surrounding biological environment often called the stem cell niche.
This environment contains blood vessels, immune cells, extracellular matrix, signaling molecules, and neighboring cells. With age, this environment can become more inflammatory and less supportive of regeneration.
This phenomenon is sometimes connected with “inflammaging,” a state of persistent low-level inflammatory activity associated with aging. Aging MSCs themselves may also change what they secrete. Recent research has highlighted altered chemokine and inflammatory signaling as one way senescent MSCs can contribute to deterioration of the stem cell niche. This means regenerative decline is not caused only by old cells. The environment surrounding those cells also changes.
Does Aging Affect Bone Marrow and Adipose Stem Cells?
Donor age can influence MSCs obtained from adult tissues, although the effect is not identical across every tissue source or every individual. Bone marrow MSCs are among the best studied. Research has reported age-related reductions in their number, proliferation, and some aspects of differentiation capacity.
Some studies of adipose-derived MSCs have also reported slower expansion and greater signs of senescence in older donors, although results across adipose tissue research have not always been completely consistent. This is why it is too simplistic to say older person’s stem cells are bad. A more accurate statement is age is one biological factor that can influence adult stem cell quantity and function, but it is not the only factor.
Why Are Umbilical Cord MSCs Considered a Young Cell Source?
Umbilical cord tissue is collected at birth, so UC-MSCs originate from perinatal tissue rather than from adult tissue that has experienced decades of biological aging. This is one reason UC-MSCs have attracted significant interest for regenerative medicine.
Comparative laboratory research has reported high proliferative capacity and lower expression of some senescence-associated markers in MSCs obtained from perinatal sources compared with several adult tissue sources. UC-MSCs can also be expanded under controlled laboratory conditions to produce defined cell numbers without requiring the patient to undergo bone marrow aspiration or fat harvesting.
However, young tissue does not automatically mean better clinical outcomes for every disease. Clinical effectiveness depends on much more than donor age. Cell source, manufacturing method, passage, viability, potency, dose, route of administration, treatment indication, and patient characteristics all matter. The value of UC-MSCs is therefore better understood as a biological and manufacturing characteristic rather than a guarantee of superior results.
Does a Younger Donor Always Mean Better Stem Cells?
No. Younger tissue may provide biological advantages such as stronger proliferative capacity and less accumulated cellular aging. But donor age alone cannot determine the quality of a clinical MSC product.
A poorly manufactured product from young tissue may still have problems with viability, contamination, excessive expansion, or inconsistent cell characteristics. Likewise, adult-derived cells from an older patient may still have useful biological properties. mFor clinical cell therapy, age needs to be considered together with cell identity, donor health, passage number, viability, sterility, manufacturing conditions, cellular expansion, and appropriate quality-control testing.
Why Does Stem Cell Age Matter in Regenerative Medicine?
Stem cells gradually accumulate biological changes as the body ages. They may become less numerous, divide more slowly, experience greater oxidative and mitochondrial stress, enter senescence more frequently, and function within a less regenerative tissue environment.
These changes help explain why age is considered when evaluating adult-derived MSCs. They also explain the scientific interest in perinatal sources such as umbilical cord tissue, which provide MSCs from a much younger biological source. However, age should never be considered in isolation. The quality of a stem cell product depends on both where the cells came from and what happened to them afterward. Donor screening, passage, culture conditions, viability, sterility, potency, transport, dose, and clinical indication remain essential parts of the overall treatment assessment.
Frequently Asked Questions
- Do stem cells become weaker as you age?
Stem cell function can gradually decline with age. Research has identified reduced proliferation, greater cellular senescence, mitochondrial changes, DNA damage, and alterations in cellular signaling as contributing factors.
- Does age mean my own stem cells cannot be used?
No. Chronological age alone does not determine whether an individual’s cells are usable. Tissue source, health, cell number, manufacturing, and biological characteristics also matter. Human bone marrow research has shown considerable variation between people of similar ages.
- Are umbilical cord stem cells younger than bone marrow stem cells?
UC-MSCs originate from tissue collected at birth, while adult bone marrow MSCs come from tissue that has aged with the donor. This makes UC-MSCs a biologically young cell source, although that does not automatically guarantee better outcomes for every clinical condition.
- Why do older stem cells divide more slowly?
Age-related DNA damage, telomere changes, oxidative stress, mitochondrial dysfunction, epigenetic alterations, and cellular senescence can all interfere with normal cell division and self-renewal.
Related Reading
- How Long Do Stem Cells Stay Alive Before Treatment?
- Benefits and Limitation of UC-MSCs
- Aging and Mesenchymal Stem Cells: How Aging Happens
About EDNA Wellness
EDNA Wellness is a surgeon-led regenerative medicine center in Bangkok, specializing in orthopedic and neurological conditions using Umbilical Cord Derived Mesenchymal Stem Cells (UC-MSCs).
All cases are reviewed by orthopedic surgeons and neurosurgeons, with a focus on clinical indication, patient safety, and realistic treatment expectations. Stem cell therapy is recommended selectively, and alternative treatments are considered when more appropriate.
For more information or to book a consultation:
LINE: @ednawellness
WhatsApp: +66 (0) 64 505 5599
Website: www.ednawellness.com
References
- Fauzi A, Wong CZE, Tee PYE, et al. Mechanistic insights into stem cell aging: Pathways and processes. Mechanisms of Ageing and Development. 2026. https://pubmed.ncbi.nlm.nih.gov/41628864/
- Goodell MA, Brunet A, et al. Hallmarks of stem cell aging. 2025 https://pubmed.ncbi.nlm.nih.gov/40562035/
- Baker N, Boyette LB, Tuan RS. Chronological Age Affects MSC Senescence In Vitro: A Systematic Review. 2021. https://pubmed.ncbi.nlm.nih.gov/34360725/
- Ganguly P, El-Jawhari JJ, Burska AN, et al. The Analysis of In Vivo Aging in Human Bone Marrow Mesenchymal Stromal Cells Using Colony-Forming Unit-Fibroblast Assay and the CD45lowCD271+ Phenotype. Stem Cells International. 2019. https://pubmed.ncbi.nlm.nih.gov/31467563/
- Cakouros D, Gronthos S. The changing epigenetic landscape of Mesenchymal Stem/Stromal Cells during aging. Bone. 2020. https://pubmed.ncbi.nlm.nih.gov/32445894/
- Cheng L, Song G. Mitochondria-Lysosome Quality Flux in Aging Mesenchymal Stem/Stromal Cells: Quality-Control Bottlenecks and Therapeutic Opportunities for Regenerative Decline. Cells. 2026. https://pubmed.ncbi.nlm.nih.gov/42738843/
- Gang EJ, Bosnakovski D, Figueiredo CA, et al. Comparative analysis of human mesenchymal stem cells from bone marrow, adipose tissue, and umbilical cord blood as sources of cell therapy. 2013. https://pubmed.ncbi.nlm.nih.gov/24005862/
